NCT01476046View on ClinicalTrials.gov

Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

March 8, 2011

Primary Completion Date

June 17, 2012

Study Completion Date

June 17, 2012

Conditions

Respiratory Disorders

Interventions

DRUG

GSK1995057 single dose

Single intravenous dose

DRUG

Placebo

Single intravenous dose

Trial Locations (1)

Unknown

GSK Investigational Site, Harrow

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01476046 - Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects. | Biotech Hunter | Biotech Hunter